Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mirati Therapeutics (NQ: MRTX ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mirati Therapeutics < Previous 1 2 3 4 5 6 7 8 Next > 12 Health Care Stocks Moving In Friday's Pre-Market Session May 27, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 26, 2022 Gainers Via Benzinga Expert Ratings for Mirati Therapeutics May 24, 2022 Within the last quarter, Mirati Therapeutics (NASDAQ:MRTX) has observed the following analyst ratings: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022 May 20, 2022 Upgrades Via Benzinga Analyst Ratings for Mirati Therapeutics May 05, 2022 Within the last quarter, Mirati Therapeutics (NASDAQ:MRTX) has observed the following analyst ratings: Via Benzinga Mirati Therapeutics: Q1 Earnings Insights May 04, 2022 Mirati Therapeutics (NASDAQ:MRTX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For February 28, 2022 February 28, 2022 Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... Via Benzinga Mirati Therapeutics's Return On Capital Employed Overview May 20, 2022 According to data from Benzinga Pro, during Q1, Mirati Therapeutics's (NASDAQ:MRTX) reported sales totaled $709.00 thousand. Despite a 5.63% increase in earnings, the company posted a loss of $188.39... Via Benzinga The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara May 20, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints May 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga Earnings Preview For Mirati Therapeutics May 03, 2022 Mirati Therapeutics (NASDAQ:MRTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Mirati... Via Benzinga 7 Potential Biotech Stocks Buyout Targets in 2022 April 21, 2022 Drug development is a cumbersome process and M&A is a win-win proposition for both the acquirer and the target company. Via InvestorPlace Deciphera's DCC-3116/KRAS Inhibitor Combo Shows Deeper, Longer Tumor Regressions In Preclinical Studies April 13, 2022 Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) Via Benzinga Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why March 09, 2022 Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside. Analyst... Via Benzinga Where Mirati Therapeutics Stands With Analysts March 01, 2022 Within the last quarter, Mirati Therapeutics (NASDAQ:MRTX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... Via Benzinga Stocks That Hit 52-Week Lows On Thursday April 21, 2022 On Thursday, 236 companies hit new 52-week lows. Via Benzinga The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight February 27, 2022 Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... Via Benzinga Preview: Mirati Therapeutics's Earnings February 25, 2022 Mirati Therapeutics (NASDAQ:MRTX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts... Via Benzinga 40 Stocks Moving In Wednesday's Mid-Day Session February 16, 2022 Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral... Via Benzinga 56 Biggest Movers From Yesterday February 17, 2022 Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... Via Benzinga Mirati Therapeutics' Adagrasib Application Under FDA Review For Lung Cancer Setting February 16, 2022 The FDA has accepted for review Mirati Therapeutics Inc's (NASDAQ: MRTX) marketing application seeking approval for adagrasib for non-small cell lung cancer (... Via Benzinga The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa February 16, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday February 16, 2022 On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday February 16, 2022 We've got another busy day of trading ahead of us so let's get right to it with the biggest pre-market stock movers for Wednesday! Via InvestorPlace 51 Biggest Movers From Yesterday February 09, 2022 Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday February 08, 2022 Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session February 08, 2022 Gainers BioCardia (NASDAQ:BCDA) stock inc... Via Benzinga 35 Stocks Moving In Tuesday's Mid-Day Session February 08, 2022 Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following... Via Benzinga Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients January 21, 2022 Mirati Therapeutics Inc (NASDAQ: MRTX) has announced data from a Phase 2 cohort of the KRYSTAL-1 study evaluating adagrasib at the 600mg BID dose in pretreated... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session January 10, 2022 Gainers Inari Medical (NASDAQ:NARI) stock... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.